DeutschNewstral
Article
Mmarketwatch.com on 2018-12-27 13:04
Boston Scientific buys remaining shares in privately held Millipede to expand its heart portfolio
Related news
- MBoston Scientific agrees to buy privately held Augmenix for $500 millionmarketwatch.com
Boston Scientific Exercises Option to Acquire Transcatheter Annuloplasty Ring Developer Millipede Inc.jdsupra.com
Nampak to expand product portfolioherald.co.zw
Tehran, Baghdad to expand scientific, technology cooperationtehrantimes.com- Powerspeed set to expand product portfolioherald.co.zw
- FMHL to expand USD-based product portfolioherald.co.zw
- TMature students’ rep moves to expand portfoliothemanitoban.com
Reynolds to expand Newport brand portfoliobizjournals.com
Hydrogen energy may expand Kern's energy portfoliobakersfield.com- TExpand Your Investment Portfolio With Real Estatetricountysentry.com
Boston Scientific Adds Another Product To Its PortfolioForbes
Group building privately funded border wall plans to expandpressherald.com- NOttawa to expand program to support privately sponsored LGBTQ refugeesnationalpost.com
- WashREIT to sell most of its remaining office, retail portfoliobizjournals.com
- Columbia Property Trust selling remaining Atlanta office portfoliobizjournals.com
Scientific Games seeks to expand digital gaming enterprisesreviewjournal.com- Scientific Games, Golden Nugget expand sports betting partnershipreviewjournal.com
- Amirkabir university, NODET to expand scientific co-optehrantimes.com
- Iran, Venezuela discuss ways to expand scientific co-optehrantimes.com